UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Contribution of limb momentum to power transfer in athletic wheelchair pushing

Journal of biomechanics, 2016-09, Vol.49 (13), p.2577-2583

2016

Volltextzugriff (PDF)

Inhibition of surface spoilage bacteria in processed meats by application of antimicrobial films prepared with chitosan

International journal of food microbiology, 2000-12, Vol.62 (1), p.139-148

2000

Volltextzugriff (PDF)

Impact of nitrogen deposition at the species level

Proceedings of the National Academy of Sciences - PNAS, 2013-01, Vol.110 (3), p.984-987

2013

Volltextzugriff (PDF)

Antibacterial activity of selected fatty acids and essential oils against six meat spoilage organisms

International journal of food microbiology, 1997-07, Vol.37 (2), p.155-162

1997

Volltextzugriff (PDF)

Antimicrobial films produced from chitosan

International journal of biological macromolecules, 1999-10, Vol.26 (1), p.63-67

1999

Volltextzugriff (PDF)

The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes

Diabetes care, 2013-04, Vol.36 (4), p.858-864

2013

Volltextzugriff (PDF)

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

The Lancet (British edition), 2012-04, Vol.379 (9825), p.1489-1497

2012

Volltextzugriff (PDF)

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

The Lancet (British edition), 2012-04, Vol.379 (9825), p.1498-1507

2012

Volltextzugriff (PDF)

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial

Diabetic medicine, 2013-11, Vol.30 (11), p.1298-1304

2013

Volltextzugriff (PDF)

Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension

The journal of clinical endocrinology and metabolism, 2013-03, Vol.98 (3), p.1154-1162

2013

Volltextzugriff (PDF)

Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)

Diabetes care, 2012-12, Vol.35 (12), p.2464-2471

2012

Volltextzugriff (PDF)

A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)

Diabetes, obesity & metabolism, 2014-07, Vol.16 (7), p.636-644

2014

Volltextzugriff (PDF)

Efficacy and Safety of Infliximab in Intestinal Behçet's Disease: A Multicenter, Phase 3 Study (BEGIN)

Gut and Liver, 2023, 17(5), , pp.777-785

2023

Volltextzugriff (PDF)

Physical Gelation of Chitosan in the Presence of β-Glycerophosphate: The Effect of Temperature

Biomacromolecules, 2005-11, Vol.6 (6), p.3267-3275

2005

Volltextzugriff (PDF)

Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trial

Diabetes, obesity & metabolism, 2014-10, Vol.16 (10), p.922-930

2014

Volltextzugriff (PDF)

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Diabetic medicine, 2013-11, Vol.30 (11), p.1293

2013

Volltextzugriff (PDF)

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Diabetic medicine, 2013-11, Vol.30 (11), p.1293-1297

2013

Volltextzugriff (PDF)

Viscoelastic properties of chitosan solutions: Effect of concentration and ionic strength

Journal of food engineering, 2006-06, Vol.74 (4), p.500-515

2006

Volltextzugriff (PDF)

Diffusion of Acetic and Propionic Acids from Chitosan-based Antimicrobial Packaging Films

Journal of food science, 2000-08, Vol.65 (5), p.768-773

2000

Volltextzugriff (PDF)

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

The New England journal of medicine, 2023-08, Vol.389 (6), p.491-503

2023

Volltextzugriff (PDF)

Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder

The journal of clinical psychiatry, 2004-03, Vol.65 (3), p.379-385

2004

Volltextzugriff (PDF)

Effect of urea on solution behavior and heat-induced gelation of chitosan-β-glycerophosphate

Carbohydrate polymers, 2006-03, Vol.63 (4), p.507-518

2006

Volltextzugriff (PDF)

Effect of organic and inorganic acids on concentrated chitosan solutions and gels

International journal of biological macromolecules, 2005-11, Vol.37 (3), p.134-142

2005

Volltextzugriff (PDF)

Effect of urea on solution behavior and heat-induced gelationof chitosan-β-glycerophosphate

Carbohydrate polymers, 2006-03, Vol.63 (4), p.507-518

2006

Volltextzugriff (PDF)

Differences in Dissociative Experiences Between Survivors of Childhood Incest and Survivors of Assault in Adulthood

The journal of nervous and mental disease, 1996-01, Vol.184 (1), p.52-54

1996

Volltextzugriff (PDF)

1 – 25 von 4.628

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.692)
Mit Volltextzugriff
(3.723)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(1.209)
Ingenta
(1.187)
Business Source Ultimate
(1.182)
Nexis Uni (LexisNexis)
(1.153)
MEDLINE
(1.004)
LWW Total
(763)
Elsevier ScienceDirect Journals
(678)
Publisher website
(589)
IngentaConnect Journals
(425)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(396)
Wiley Online Library
(303)
Wiley Online Library Full Collection 2018
(238)
Springer Journals
(225)
JSTOR
(164)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(134)
Taylor & Francis
(134)
Taylor & Francis Journals
(128)
Taylor & Francis:Master (3349 titles)
(123)
ProQuest Dissertations & Theses A&I
(110)
SAGE Journals Online
(98)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Contribution of limb momentum to power transfer in athletic wheelchair pushing

Inhibition of surface spoilage bacteria in processed meats by application of antimicrobial films prepared with chitosan

Impact of nitrogen deposition at the species level

Antibacterial activity of selected fatty acids and essential oils against six meat spoilage organisms

Antimicrobial films produced from chitosan

The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial

Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension

Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)

A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)

Efficacy and Safety of Infliximab in Intestinal Behçet's Disease: A Multicenter, Phase 3 Study (BEGIN)

Physical Gelation of Chitosan in the Presence of β-Glycerophosphate: The Effect of Temperature

Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trial

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Viscoelastic properties of chitosan solutions: Effect of concentration and ionic strength

Diffusion of Acetic and Propionic Acids from Chitosan-based Antimicrobial Packaging Films

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder

Effect of urea on solution behavior and heat-induced gelation of chitosan-β-glycerophosphate

Effect of organic and inorganic acids on concentrated chitosan solutions and gels

Effect of urea on solution behavior and heat-induced gelationof chitosan-β-glycerophosphate

Differences in Dissociative Experiences Between Survivors of Childhood Incest and Survivors of Assault in Adulthood

Suchergebnisse filtern